🇺🇸 FDA
Pipeline program

Rasagiline/Placebo

IIT-TN-067

Approved small_molecule completed

Quick answer

Rasagiline/Placebo for Parkinson's Disease is a Approved program (small_molecule) at TEVA PHARMACEUTICAL INDUSTRIES LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TEVA PHARMACEUTICAL INDUSTRIES LTD
Indication
Parkinson's Disease
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials